Iron Horse Wealth Management’s AstraZeneca AZN Stock Holding History

Iron Horse Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$3.91K	Hold	28	–	–	﹤0.01%	405
2025 Q1	$4.12K	Sell	28 -49	-64%	-$7.09K	﹤0.01%	389
2024 Q4	$10K	Hold	77	–	–	﹤0.01%	240
2024 Q3	$11.9K	Buy	77 +57	+285%	+$9.2K	﹤0.01%	221
2024 Q2	$3.12K	Hold	20	–	–	﹤0.01%	317
2024 Q1	$2.71K	Hold	20	–	–	﹤0.01%	312
2023 Q4	$2.69K	Hold	20	–	–	﹤0.01%	327
2023 Q3	$2.71K	Buy	+20	New	+$2.73K	﹤0.01%	325

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Iron Horse Wealth Management's AZN Position: Q2 2025 in Review

Iron Horse Wealth Management held its AstraZeneca (AZN) position steady in Q2 2025 at 28 shares worth $3.91K. The position accounts for ﹤0.01% of the portfolio, ranked #405.

Iron Horse Wealth Management first reported a position in AZN in Q3 2023 and has held it in 8 quarters since. The position peaked at $11.9K in Q3 2024. 1,223 funds tracked by Wall St. Rank hold AZN as of Q2 2025.

Iron Horse Wealth Management held 28 shares of AstraZeneca worth $3.91K as of Q2 2025.
Iron Horse Wealth Management left its AstraZeneca share count unchanged in Q2 2025.
AstraZeneca made up ﹤0.01% of Iron Horse Wealth Management's portfolio in Q2 2025, its #405 holding.
Iron Horse Wealth Management first reported a position in AstraZeneca in Q3 2023 and has held it in 8 quarters since.
Iron Horse Wealth Management's AstraZeneca position peaked at $11.9K in Q3 2024.
1,223 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2025.

Based on Iron Horse Wealth Management's 13F filing for Q2 2025, filed 22 Jul 2025.